Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.74 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.74 |
| ▸ | LMNA | P02545 | 2/20 | 0.74 |
| ▸ | HSPD1 | P10809 | 2/20 | 0.74 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.74 |
| ▸ | HSPE1 | P61604 | 2/20 | 0.74 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.74 |
| ▸ | AR | P10275 | 1/20 | 0.74 |
| ▸ | TSHR | P16473 | 1/20 | 0.74 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.74 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.74 |
| ▸ | USP2 | O75604 | 1/20 | 0.74 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.74 |
| ▸ | ESR1 | P03372 | 1/20 | 0.74 |
| ▸ | TST | Q16762 | 1/20 | 0.74 |
| ▸ | MAPT | P10636 | 3/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.67 |
| ▸ | SREBF1 | P36956 | 1/20 | 0.67 |
| ▸ | VDR | P11473 | 5/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31602211 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| SCHEMBL15261726 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| SCHEMBL4948460 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| SCHEMBL1249402 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| SCHEMBL19733279 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| SCHEMBL29504071 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| SCHEMBL18393817 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| SCHEMBL1249404 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| SCHEMBL5917213 | 0.93 | ALDH1A1 (0.72) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| SCHEMBL5917211 | 0.93 | ALDH1A1 (0.72) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119322137-A | Liquid chromatography tandem mass spectrometry detection method for serum vitamin D metabolic pathway metabolites | 凯莱谱科技股份有限公司 | 2025-01-17 | — | — | CN | claimed |
| US-12459905-B2 | Reagent for mass spectrometry | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2025-11-04 | — | — | US | disclosed |
| EP-4623304-A1 | DERIVATISATION AGENT FOR LASER DESORPTION IONIZATION MASS SPECTROMETRY | F. Hoffmann-La Roche AG (CH) | 2025-10-01 | — | — | EP | disclosed |
| US-20250277801-A1 | DERIVATISATION AGENT FOR LASER DESORPTION IONIZATION MASS SPECTROMETRY | ROCHE DIAGNOSTICS OPERATIONS, INC. | 2025-09-04 | — | — | US | disclosed |
| CN-119322137-A | Liquid chromatography tandem mass spectrometry detection method for serum vitamin D metabolic pathway metabolites | 凯莱谱科技股份有限公司 | 2025-01-17 | — | — | CN | disclosed |
| WO-2024110385-A1 | DERIVATISATION AGENT FOR LASER DESORPTION IONIZATION MASS SPECTROMETRY | F. HOFFMANN-LA ROCHE AG (CH) | 2024-05-30 | — | — | WO | disclosed |
| US-20240092742-A1 | REAGENT FOR MASS SPECTROMETRY | ROCHE DIAGNOSTICS OPERATIONS, INC. | 2024-03-21 | — | — | US | disclosed |
| US-11885818-B2 | Reagent for mass spectrometry | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2024-01-30 | — | — | US | disclosed |
| US-11845733-B2 | Reagent for mass spectrometry | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2023-12-19 | — | — | US | disclosed |
| CN-113311080-B | Joint detection method for multiple vitamin D metabolites, detection kit and application thereof | 中国医学科学院北京协和医院 | 2023-02-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12459905-B2 | Reagent for mass spectrometry | SRMS, PTMS, MMAB | ALDH1A1 83/4885ALOX15 1040/4885CYP3A4 133/4885 |
| US-20240092742-A1 | REAGENT FOR MASS SPECTROMETRY | SRMS, PTMS, MMAB | ALDH1A1 83/4885ALOX15 1040/4885CYP3A4 133/4885 |
| US-11885818-B2 | Reagent for mass spectrometry | SRMS, PTMS, MMAB | ALDH1A1 83/4885ALOX15 1040/4885CYP3A4 133/4885 |
| US-11845733-B2 | Reagent for mass spectrometry | SRMS, PTMS, MMAB | ALDH1A1 83/4885ALOX15 1040/4885CYP3A4 133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.